Zalgen develops, manufactures, and markets critical components and diagnostic products for neglected tropical diseases. Our extensive product line includes recombinant antigens, polyclonal and monoclonal antibodies (including HuMAbs), and diagnostic test kits for research testing of Lassa, Ebola and other hemorrhagic fever viruses. In 2020 we launched the first of our new test kits and critical reagents for SARS CoV-2.
ELISA and Lateral Flow Immunoassay research products for Lassa and Ebola
Extensive line of human and mouse monoclonal antibodies to LASV glycoproteins and nucleoproteins
Unique recombinant Lassa glycoproteins, nucleoproteins and VLP’s
Test kits and recombinant proteins
Research ELISA products configured for NHP and other animal models